Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Imprimis Pharmaceuticals, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Imprimis Pharmaceuticals, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Imprimis Pharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is IMMY. The reporting company's CIK number is 1360214.
The total value of stock buying since 2005 is $1,008,156.
The total value of stock sales since 2005 is $3,310,750.
The total value of stock option exercises since 2005 is $922,982.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2018-02-01||Saharek John P. (Chief Commercial Officer)||Option Ex||30,000||1.83||54,900|
|2018-02-01||Boll Andrew R. (Chief Financial Officer)||Option Ex||30,000||1.83||54,900|
|2017-07-17||Kammer Robert J||Sale||10,000||3.05||30,530|
|2016-12-19||Boll Andrew R. (Chief Financial Officer)||Buy||39,000||1.79||69,810|
|2016-12-19||Baum Mark L (Chief Executive Officer)||Buy||156,000||1.79||279,240|
|2016-12-19||Baum Mark L (Chief Executive Officer)||Option Ex||200,000||1.72||344,000|
|2016-12-19||Lindstrom Richard L Md||Buy||100,000||1.79||179,000|
|2016-03-11||Opaleye Management Inc.||Buy||45,000||3.65||164,250|
|2016-02-01||Boll Andrew R. (Chief Financial Officer)||Option Ex||15,000||3.68||55,200|
|2015-06-30||Opaleye Management Inc.||Buy||35,000||7.90||276,500|
|2015-05-19||Opaleye Management Inc.||Buy||2,801||8.00||22,408|
|2015-05-19||Miloni Donald Paul||Sale||110,000||8.00||880,220|
|2015-05-18||Miloni Donald Paul||Sale||300,000||8.00||2,400,000|
|2015-04-23||Kammer Robert J||Option Ex||15,282||5.92||90,545|
|2014-09-30||Kammer Robert J||Option Ex||71,875||4.50||323,437|
|2008-09-29||Singh Juliet (CEO, Director and President)||Buy||500||1.40||700|
|2008-09-26||Singh Juliet (CEO, Director and President)||Buy||500||1.40||700|
|2008-09-25||Thornley Anthony S (Director)||Buy||3,000||1.05||3,150|
|2008-09-23||Thornley Anthony S (Director)||Buy||3,000||1.25||3,750|
|2008-09-10||Thornley Anthony S (Director)||Buy||500||1.42||710|
|2008-09-03||Thornley Anthony S (Director)||Buy||200||1.65||330|
|2008-09-02||Thornley Anthony S (Director)||Buy||200||1.50||300|
|2008-06-27||Thornley Anthony S (Director)||Buy||4,200||1.74||7,308|
Insider trading activities including stock purchases, stock sales, and option exercises of IMMY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Imprimis Pharmaceuticals, Inc. (symbol IMMY, CIK number 1360214) see the Securities and Exchange Commission (SEC) website.